Clinical trials
Neurological Diseases or Conditions clinical trials
Below are recruiting neurological diseases or conditions clinical trials, each written for real people, not researchers. We’re tracking 4,613 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07060638RecruitingPhase 2
Combination therapy for severe alcoholic hepatitis
This trial tests a combination of treatments for people with severe alcohol-related liver disease (alcoholic hepatitis) that has not responded to standard care. The goal is to improve liver function and help you stop drinking.
Indianapolis, IndianaAges 18–70 - NCT06936566RecruitingPhase 2
Ruxolitinib for graft-versus-host disease after transplant
This trial tests a drug called ruxolitinib for treating acute graft-versus-host disease (aGVHD), a common complication after a stem cell transplant. It may help control the immune reaction without using high doses of steroids.
Duarte, CaliforniaAges 18 years+ - NCT06975111RecruitingPhase 2/Phase 3
Improving health during menopause
This trial studies ways to help women during the late menopausal transition. It uses a smartphone app and telehealth visits to track your health and help you feel better.
Aurora, ColoradoAges 45–55 - NCT06838442Recruiting
Exercise and airway clearance education for NTM lung disease
This trial studies whether a program of exercise and airway clearance education helps people with nontuberculous mycobacterial (NTM) lung disease. It aims to improve breathing and quality of life.
Seongnam-si, Gyeonggi-doAges 20 years+ - NCT06851806Recruiting
Palivizumab study for children at high risk of severe RSV
This study tests a medication called palivizumab to help protect certain children from severe RSV (a common respiratory virus). It is for infants and young children with a higher chance of getting very sick from RSV, such as premature babies or those with certain heart or lung conditions.
HyderabadAges Any age - NCT06805682Recruiting
Study of young children in child protective care
This study follows young children (under 3.5 years) who are under child protective services, to better understand their health and needs. It aims to improve care for vulnerable children.
Évreux, FranceAges birth–3.5 years - NCT06832774RecruitingPhase 2
Hormone therapy plus local treatment for advanced prostate cancer
This study tests adding a targeted local treatment (like radiation or surgery) to standard hormone therapy for men with advanced prostate cancer that still shows up on a special scan. The goal is to see if this combination helps control the cancer better.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06769165Recruiting
EMDR for nausea and vomiting in cancer survivors
This trial tests if EMDR therapy can help reduce nausea and vomiting that some people continue to experience long after finishing cancer treatment.
Groningen, Provincie GroningenAges 16 years+ - NCT06611839RecruitingPhase 1/Phase 2
Combination therapy for IDH1-mutated AML
This trial tests a combination of three drugs (venetoclax, ivosidenib, and azacitidine) for people newly diagnosed with a specific type of AML that has an IDH1 mutation. The goal is to see if this mix works better than standard treatments.
Tianjin, Tianjin MunicipalityAges 14 years+ - NCT06657391RecruitingPhase 2
Study of a new drug to prevent graft-versus-host disease in thalassemia patients
This trial tests a drug called an anti-CD25 antibody to see if it can prevent graft-versus-host disease (a condition where donor cells attack the body) in people with transfusion-dependent thalassemia who are getting a stem cell transplant from a partially matched or unrelated donor.
Maoming, GuangdongAges 3–20 - NCT06661967Recruiting
Numbing gel for breathing tube insertion in emergencies
This trial tests if adding a numbing gel to standard care helps doctors insert a breathing tube more quickly on the first try. If you need a breathing tube in the emergency room and are over 18, you may be able to join.
Chon Buri, Changwat Chon BuriAges 18 years+ - NCT06581900Recruiting
Vitamin B12 in kids with sickle cell disease
This study looks at how children with sickle cell disease process vitamin B12 when exposed to a gas painkiller called MEOPA. It may help doctors understand how to manage treatment better.
ReimsAges 2–18 - NCT06556550RecruitingPhase 2/Phase 3
Targeted radiation for limited cancer spread vs. standard care
This trial tests whether high-precision radiation (SBRT) can improve outcomes for people with up to 5 small, stable metastases from certain cancers, compared to usual palliative care. It is for those whose disease is not growing after current chemotherapy.
Obninsk, Kaluga OblastAges 18 years+ - NCT06420310Recruiting
Pesticides and Parkinson's disease study
This study looks at how pesticides might be linked to Parkinson's disease by comparing farmers who have been exposed to pesticides with people who have not been exposed. It aims to help understand what causes the disease.
BurgosAges 45–55 - NCT06479252Recruiting
Comparing ways to test sit-to-stand in chronic lung disease
This study compares three ways of doing a simple sit-to-stand test for people with chronic lung disease: at the clinic, at home with video supervision, or on your own at home. The goal is to see which option works best and is easiest for patients.
Toronto, OntarioAges 18 years+ - NCT06419062Enrolling by invitation
Using wearables to monitor COPD at home
This study tests if a wearable device can help track your COPD symptoms between doctor visits. You'll use a smartphone or computer to share data, which may help your care team stay on top of your health.
GlasgowAges 18 years+ - NCT06463366Recruiting
Using MRI to better diagnose liver fat, inflammation, and scarring
This study uses advanced MRI scans to get a clearer picture of liver fat, inflammation, and scarring in people with chronic liver disease. It aims to help doctors diagnose and understand liver problems better.
Shenyang, LiaoningAges 18–75 - NCT06208137Recruiting
Using immune risk score to guide recovery after stem cell transplant
This study uses a special score (immune risk score) to check how well your immune system rebuilds after a half-matched stem cell transplant. The goal is to find patients who might need extra help with immune recovery.
Tianjin, Tianjin MunicipalityAges 16 years+ - NCT06203132RecruitingPhase 3
Doravirine vs Dolutegravir for first-time HIV treatment
This study compares two HIV medicines, doravirine and dolutegravir, to see which works better for people who have never taken HIV treatment before. If you qualify, you would be randomly assigned to one of the two medications.
Nova Iguaçu, Rio de JaneiroAges 18 years+ - NCT06062017Recruiting
Potassium, hydration, and heart health in young adults
This study looks at how potassium and hydration affect heart and kidney health in healthy young adults. It may help you understand your own health and contribute to new knowledge about preventing disease.
Auburn, AlabamaAges 18–30 - NCT05940441Recruiting
Low-dose capecitabine after throat cancer treatment
This study tests whether low-dose capecitabine given after standard treatment can lower the chance that locoregional (nearby) throat cancer returns. It is designed for adults with advanced hypopharyngeal (throat) cancer who have finished curative chemoradiation or surgery and follow-up therapy and show no active cancer on exam.
ShanghaiAges 18–65 - NCT06087029Recruiting
Improving outcomes in aortic dissection
This study tests a minimally invasive procedure called TEVAR to repair a type B aortic dissection (a tear in the wall of the main artery from your heart). It may help prevent further damage and improve recovery.
Birmingham, AlabamaAges 21 years+ - NCT05806450Recruiting
Sleep training for parents and babies using online sessions
This trial tests an online sleep program meant to improve sleep for parents and young children. It may help families that want better nighttime routines and sleep quality for babies aged 6 to 24 months.
SeoulAges 6 months–2 years - NCT05766280Recruiting
Online soft-skills coaching for young people with mental health needs
This study tests an internet-based program that helps young adults build “soft skills” they need for work, like communicating and getting along with others. You may be able to join if you’re in the right age range, have a mental health–related support plan, and are currently stable enough to participate.
Newark, New JerseyAges 16–24
Hear when a new Neurological Diseases or Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurological diseases or conditions?
- Yes. Clin2 currently lists 4,613 recruiting neurological diseases or conditions studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurological diseases or conditions trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurological diseases or conditions trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.